Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenues:    
Total revenues $ 211,466 $ 222,451
Costs and expenses:    
Selling, general and administrative 76,132 95,158
Research and development 21,760 36,529
Contingent consideration (860) 4,806
Amortization of intangible assets 14,938 16,562
Asset impairment charges 0 655
Total costs and expenses 252,228 297,769
Operating loss (40,762) (75,318)
Other income and (expense), net:    
Interest income 142 556
Interest expense (5,496) (4,755)
Fair value changes of derivative instruments, net 621 415
Other income (expense), net (12,332) 977
Other income and (expense), net (17,065) (2,807)
Loss before income taxes and investment losses (57,827) (78,125)
Income tax provision (1,171) (783)
Net loss before investment losses (58,998) (78,908)
Loss from investments in investees (134) (1,854)
Net loss $ (59,132) $ (80,762)
Loss per share, basic and diluted:    
Loss per share (in dollars per share) $ (0.09) $ (0.14)
Weighted average common shares outstanding, basic and diluted (in shares) 640,578,794 586,344,207
Services    
Revenues:    
Total revenues $ 170,839 $ 178,891
Costs and expenses:    
Cost of service revenue 122,887 129,903
Products    
Revenues:    
Total revenues 31,074 25,301
Costs and expenses:    
Cost of service revenue 17,371 14,156
Revenue from transfer of intellectual property and other    
Revenues:    
Total revenues $ 9,553 $ 18,259